Cyamamezine-induced acute hepatitis after unique massive intake: A case report

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 4, 1999, Pages 451-453

  Cadranel, Jean François ^a   Bonnard, Philippe ^a   Cazier, Alain ^a   Di Martino, Vincent ^a   Pras, Veronique ^b   Devergie, Bruno ^a   Biour, Michel ^b  

^a CENTRE HOSPITALIER LAENNEC   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Hepatitis; Phenothiazine

Indexed keywords

CYAMEMAZINE; PHENOTHIAZINE; TERFENADINE;

ACUTE HEPATITIS; ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; LIVER TOXICITY; PRIORITY JOURNAL; SUICIDE ATTEMPT;

EID: 0032898812     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199904000-00016     Document Type: Article

References (15)

1. Rager P, Cosculluela D, Deviers D. Hépatite medicamenteuse. Rôle possible de la cyamamézine [Letter]. Presse Med 1983; 12:1941.
2. Bleichner G, Squara P, Parent A. Hypertonia and malignant hyperthermia due to morphine and neuroleptic. Lancet 1981; 1:386-387.
3. Remy AJ, Larrey D, Pageaux GP, Ribstein J, Ramos J, Michel H. Cross reactivity between tricyclic antidepressants and phenothiazines. Eur J Gastroenterol Hepatol 1995; 7:373-376.
4. Degott C, Felmann G, Larrey D, Duranol-Schneider AM, Grangé JD, Machayekhi JP, et al. Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating ductopenia. Hepatology 1992; 15:244-251.
5. Criteria for Drug-Induced Liver Disorders: Report of an International Consensus Meeting. J Hepatol 1990; 11:272-276.
6. Biour M, Poupon R, Grangé JD, Chazouilléres O, Lėvy VG, Jaillon P. Hépatotoxicitė des mėdicaments. Mise ȧ jour du fichier bibliographique des atteintes hėpatiques et des mèdicaments responsables. Gastroenterol Clin Biol 1997; 21:660-696.
7. Stricker BHC, Biour M, Wilson JMP. Psychopharmaceutical agents. In: Drug-Induced Hepatic Injury, 2nd edition. Stricker BHC (editor). Amsterdam: Elsevier; 1992. pp. 412-460.
8. Zimmermann HJ. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals in the Liver. New York: Appleton-Century-Crofts; 1978.
9. Ishak KG, Irey NS. Hepatic injury associated with the phenothiazines: clinicopathologic and follow-up study of 36 patients. Arch Pathol 1972; 93:293-304.
10. R use: a case report. Eur J Gastroenterol 1992; 4:943-945.
11. Farrel GC. Drug-induced cholestasis. In: Drug-Induced Liver Disease. Farrel GC (editor). Edinburgh: Churchill Livingstone; 1994. pp. 319-369.
12. King PD, Blitzer BL. Drug-induced cholestasis: pathogenesis and clinical features. Sem Liver Dis 1990; 10:316-321.
13. Okanoue T, Kondo I, Ihrig TJ, French SW. Effect of ethanol and chlorpromazine on hepatic transport and biliary secretion of horseradish peroxidase. Hepatology 1984; 4:253-260.
14. Miyaziki A, Smith CR, Phillips MJ. Effect of chlorpromazine hydrochloride on contraction of bile canaliculi: evidence from microinjection studies [Abstract]. Hepatology 1985; 5:995.
15. Aberboom T, Schneider I, von Dahl S, Sies H. Cholestasis and changes of portal pressure caused by chlorpromazine in the perfused rat liver. Hepatotogy 1991; 13:216-221.